PANMINERVA MEDICA, vol.41, no.2, pp.125-128, 1999 (SCI-Expanded)
Background. Thrombomodulin (TM) is a glycoprotein and besides its anticoagulant property it is accepted as an once developmental antigen. Considering these properties we hypothesised that active TMB might have a role in cancer cell behaviour,